The report will be delivered in 2-3 business days.

Cancer Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030

Starting Price : $5000 | Pages : 175 | Published : March 2021 | SKU CODE : 7198 | Format :


The cancer diagnostics market consists of sales of cancer diagnostic devices and equipment. Cancer diagnostic equipment is used to identify biomarkers, proteins and symptoms in order to detect a cancerous tumor in the patient. Cancer diagnostics market is segmented into companion diagnostics and molecular diagnostics.

The cancer diagnostics market covered in this report is segmented by products into companion diagnostics, molecular diagnostics. The cancer diagnostics market is also segmented by end-user into cancer research institutes, diagnostic laboratories, hospitals, others; by method into biopsy, endoscopy, tumor biomarker tests, imaging; by application into cervical cancer, breast cancer, liver cancer, blood cancer, kidney cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, others.

The global cancer diagnostics market is expected to grow from $156.27 billion in 2020 to $170.21 billion in 2021 at a compound annual growth rate (CAGR) of 8.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cancer diagnostics market is expected to reach $239.23 billion in 2025 at a CAGR of 8.9%.

A high prevalence rate of various types of cancers is a major driver of the cancer diagnostics market. This is because the increasing incidences of various types of cancers is leading to a greater number of people opting for diagnosis and treatment. In addition, according to the World Health Organization (WHO), cancer was the second-leading cause of death worldwide. The National Cancer Institute (NCI) has estimated the number of new cancer cases per year to reach 23.6 million by 2030.

Product recall is one of the major restraints for the cancer diagnostics market. Product recall is a process of retrieving all faulty and defective products that have been sold or are available in the market. When a company recalls a product from the market, it takes up the cost of fixing the defective product and replacing it. This cost of replacement of cancer diagnostics devices can be very high for manufacturers, which ultimately restricts the growth of the market. For example, Siemens Healthcare Diagnostics had to recall its IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay as it was not meeting the required high-dose hook effect expectation. An IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay can be used as an aid in the detection of prostate cancer along with digital rectal examination (DRE) in men aged 50 years or older.

AI-based cancer detection system is an emerging trend in the cancer diagnostics market. AI helps in improving the accuracy of image detection in diagnostic processes such as breast cancer and lung cancer diagnostics, by detecting the cancers in early stages. AI also reduces the instances of false positives in lung cancer screening, thus, improving the lung cancer detection accuracy. For instance, researchers at the Naval Medical Center San Diego and Google's AI research division Google AI, developed a reliable solution comprised of cancer-detecting algorithms used for autonomous evaluation of lymph node biopsies. This AI solution improved the accuracy of metastatic breast cancer detection to 99%.

The cancer diagnostics market is regulated by the FDA which imposes restrictions on cancer diagnostic devices such as magnetic resonance imaging (MRI) and nuclear magnetic resonance spectroscopy (NMR). The FDA categorizes these devices into class II category, as they have a moderate risk associated with usage. Class II devices are bounded by device specific regulations which include performance standards, premarket data requirements, post market surveillance and labelling requirements associated with their usage. For instance, the labelling of such devices is required to have a list of contraindications, adverse reactions, precautions, warnings and other instructions before being released in the market. Hence, regulations such as these would keep a check on manufacturers of cancer diagnostics devices.

Major players in the cancer diagnostics market are Abbott, Becton Dickinson and Company, Hoffmann-La Roche Ltd, GE Healthcare Ltd., and Thermo Fisher Scientific.

The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global cancer diagnostics market is segmented -

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Others

3) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

4) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Others

    1. Executive Summary

    2. Cancer Diagnostics Market Characteristics

    3. Cancer Diagnostics Market Trends And Strategies

    4. Impact Of COVID-19 On Cancer Diagnostics

    5. Cancer Diagnostics Market Size And Growth

    5.1. Global Cancer Diagnostics Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Cancer Diagnostics Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Cancer Diagnostics Market Segmentation

    6.1. Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Companion diagnostics

    Molecular diagnostics

    6.2. Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cancer Research Institutes

    Diagnostic Laboratories

    Hospitals

    Others

    6.3. Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Biopsy

    Endoscopy

    Tumor Biomarker Tests

    Imaging

    6.4. Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cervical Cancer

    Breast Cancer

    Liver Cancer

    Blood Cancer

    Kidney Cancer

    Colorectal Cancer

    Pancreatic Cancer

    Ovarian Cancer

    Melanoma

    Others

    7. Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Cancer Diagnostics Market

    8.1. Asia-Pacific Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.4. Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Cancer Diagnostics Market

    9.1. China Cancer Diagnostics Market Overview

    9.2. China Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.4. China Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Cancer Diagnostics Market

    10.1. India Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.3. India Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Cancer Diagnostics Market

    11.1. Japan Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.3. Japan Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Cancer Diagnostics Market

    12.1. Australia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.3. Australia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Cancer Diagnostics Market

    13.1. Indonesia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.3. Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Cancer Diagnostics Market

    14.1. South Korea Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.3. South Korea Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Cancer Diagnostics Market

    15.1. Western Europe Cancer Diagnostics Market Overview

    15.2. Western Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.4. Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Cancer Diagnostics Market

    16.1. UK Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.3. UK Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Cancer Diagnostics Market

    17.1. Germany Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.3. Germany Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Cancer Diagnostics Market

    18.5. France Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.6. France Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.7. France Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Cancer Diagnostics Market

    19.1. Eastern Europe Cancer Diagnostics Market Overview

    19.2. Eastern Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.4. Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Cancer Diagnostics Market

    20.1. Russia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.3. Russia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Cancer Diagnostics Market

    21.1. North America Cancer Diagnostics Market Overview

    21.2. North America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.4. North America Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Cancer Diagnostics Market

    22.1. USA Cancer Diagnostics Market Overview

    22.2. USA Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.4. USA Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Cancer Diagnostics Market

    23.1. South America Cancer Diagnostics Market Overview

    23.2. South America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.4. South America Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Cancer Diagnostics Market

    24.1. Brazil Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.3. Brazil Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Cancer Diagnostics Market

    25.1. Middle East Cancer Diagnostics Market Overview

    25.2. Middle East Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.4. Middle East Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Cancer Diagnostics Market

    26.1. Africa Cancer Diagnostics Market Overview

    26.2. Africa Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.4. Africa Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Cancer Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Cancer Diagnostics Market Competitive Landscape

    27.2. Cancer Diagnostics Market Company Profiles

    27.2.1. Abbott

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Becton Dickinson and Company 

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Hoffmann-La Roche Ltd

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. GE Healthcare Ltd.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Thermo Fisher Scientific

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Cancer Diagnostics Market

    29. Cancer Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47: Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 48: North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 49: North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 50: North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 51: USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 52: USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 53: USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 54: South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 55: South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 56: South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 57: Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 58: Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 59: Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 60: Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 61: Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 62: Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 63: Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 64: Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 65: Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 66: Abbott Financial Performance
  • Table 67: Becton Dickinson and Company  Financial Performance
  • Table 68: Hoffmann-La Roche Ltd Financial Performance
  • Table 69: GE Healthcare Ltd. Financial Performance
  • Table 70: Thermo Fisher Scientific Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47: Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 48: North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 49: North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 50: North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 51: USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 52: USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 53: USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 54: South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 55: South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 56: South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 57: Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 58: Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 59: Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 60: Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 61: Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 62: Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 63: Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 64: Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 65: Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 66: Abbott Financial Performance
  • Figure 67: Becton Dickinson and Company  Financial Performance
  • Figure 68: Hoffmann-La Roche Ltd Financial Performance
  • Figure 69: GE Healthcare Ltd. Financial Performance
  • Figure 70: Thermo Fisher Scientific Financial Performance
Global Clinical Oncology Next Generation Sequencing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cervical Cancer Diagnostics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cerebrospinal Fluid Management (CSF) Devices And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Culture Consumables And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global CAR-T Therapy Pipeline Analysis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cardiovascular Surgery Devices And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cardiovascular Medical Lasers Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Cancer biologics Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Drugs For Hormonal Replacement Therapy Global Market Report 2021: COVID-19 Impact And Recovery To 2030
View Report
Molecular Diagnostics Devices And Equipment Global Market Report 2021: COVID 19 Implications And Growth to 2030
View Report
Cervical Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)